Huayi Technology at EANM 2025 in Barcelona
The European Association of Nuclear Medicine (EANM) Annual Congress 2025 was held grandly at the International Convention Center in Barcelona, Spain, from October 4th to October 8th. Coinciding with the 40th anniversary of EANM's foundation, this year's congress centered on the core themes of "Focus on Theranostics and Cancer Prevention & Treatment." It attracted nearly ten thousand experts, scholars, and industry representatives from over 130 countries, collectively witnessing this most large-scale and influential professional gathering in the global nuclear medicine field.
It is worth noting that this marked the 17th appearance of Jiangsu Huayi Technology on the EANM stage. Showcasing its comprehensive radiopharmaceutical solutions, Huayi Technology engaged in in-depth exchanges with research institutions, medical organizations, and industry partners from Europe, the Americas, Asia, and beyond. The atmosphere at the booth was vibrant, with numerous international peers showing strong interest in the rapid development and professional expertise demonstrated by Chinese enterprises in the fields of radiopharmaceuticals and related consumables.
During the congress, the Huayi team shared its experiences and insights regarding radiopharmaceutical development and industrialization. They also held productive discussions with various parties on future technological collaboration, quality system development, and sustainable supply assurance.
The autumn in Barcelona was filled with sunshine and the convergence of ideas. Experts, corporate representatives, and researchers from around the world engaged in lively discussions on the latest advancements in theranostics—spanning molecular imaging, targeted therapy, and radioisotope innovation—injecting fresh momentum into the future development of nuclear medicine. Huayi Technology's participation was not just a presentation, but also a process of learning and co-creation: gaining insights into international cutting-edge trends through communication, while simultaneously showcasing the solid strength of China's nuclear medicine industry chain to the world.
Throughout the congress, we established new connections with multiple international partners and further deepened existing cooperative relationships, accumulating valuable resources for our future global strategy. As an enterprise rooted in China and serving the world, Huayi Technology remains committed to the principles of "Innovation, Professionalism, Collaboration, and Win-Win," dedicated to providing increasingly reliable support for the global radiopharmaceutical industry.
As the EANM 2025 congress concluded successfully at this 40th-anniversary milestone, a new journey has already begun. EANM 2026 will be held in Vienna, Austria, and Huayi Technology looks forward to reuniting with global peers there to collectively witness further possibilities and breakthroughs in the field of nuclear medicine.